Serotonin drives aggression and social behaviors of laboratory male mice in a semi-natural environment.

aggression machine learning serotonin social visible burrow system

Journal

Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952

Informations de publication

Date de publication:
2024
Historique:
received: 17 06 2024
accepted: 29 08 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 3 10 2024
Statut: epublish

Résumé

Aggression is an adaptive social behavior crucial for the stability and prosperity of social groups. When uncontrolled, aggression leads to pathological violence that disrupts group structure and individual wellbeing. The comorbidity of uncontrolled aggression across different psychopathologies makes it a potential endophenotype of mental disorders with the same neurobiological substrates. Serotonin plays a critical role in regulating impulsive and aggressive behaviors. Mice lacking in brain serotonin, due to the ablation of tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme in serotonin synthesis, could serve as a potential model for studying pathological aggression. Home cage monitoring allows for the continuous observation and quantification of social and non-social behaviors in group-housed, freely-moving mice. Using an ethological approach, we investigated the impact of central serotonin ablation on the everyday expression of social and non-social behaviors and their correlations in undisturbed, group-living

Identifiants

pubmed: 39359324
doi: 10.3389/fnbeh.2024.1450540
pmc: PMC11446219
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1450540

Informations de copyright

Copyright © 2024 Rivalan, Alonso, Mosienko, Bey, Hyde, Bader, Winter and Alenina.

Déclaration de conflit d'intérêts

YW owns equity in PhenoSys. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Marion Rivalan (M)

Humboldt University Institute of Biology, Chair of Cognitive Neurobiology, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Institute of Neuroscience Paris-Saclay, CNRS, Université Paris-Saclay, Saclay, France.

Lucille Alonso (L)

Humboldt University Institute of Biology, Chair of Cognitive Neurobiology, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
University of Bordeaux, CNRS, IINS, UMR 5297, Bordeaux, France.

Valentina Mosienko (V)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
University of Bristol, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University Walk, Bristol, United Kingdom.

Patrik Bey (P)

Humboldt University Institute of Biology, Chair of Cognitive Neurobiology, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology with Experimental Neurology, Brain Simulation Section, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Alexia Hyde (A)

Humboldt University Institute of Biology, Chair of Cognitive Neurobiology, Berlin, Germany.

Michael Bader (M)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Institute for Biology, University of Lübeck, Lübeck, Germany.

York Winter (Y)

Humboldt University Institute of Biology, Chair of Cognitive Neurobiology, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Natalia Alenina (N)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

Classifications MeSH